Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 2062
of 104Next
1:

Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.

Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'Hare MJ.

Breast Cancer Res. 2006;8(5):R56.

PMID: 17014703 [PubMed - indexed for MEDLINE]

2:

Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.

Smalley MJ, Iravani M, Leao M, Grigoriadis A, Kendrick H, Dexter T, Fenwick K, Regan JL, Britt K, McDonald S, Lord CJ, Mackay A, Ashworth A.

Breast Cancer Res. 2007;9(6):R85.

PMID: 18067675 [PubMed - indexed for MEDLINE]

3:

Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.

Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L, Dexter T, Davies S, Bulmer K, Ford E, Parry S, Budroni M, Palmieri G, Neville AM, O'Hare MJ, Lakhani SR.

Cancer Res. 2004 May 1;64(9):3037-45.

PMID: 15126339 [PubMed - indexed for MEDLINE]

4:

Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

Breast Cancer Res. 2007;9(5):R59.

PMID: 17850661 [PubMed - indexed for MEDLINE]

5:

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.

Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.

BMC Genomics. 2006 May 26;7:127.

PMID: 16729877 [PubMed - indexed for MEDLINE]

6:

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.

Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO.

Int J Cancer. 2005 Sep 1;116(3):340-50.

PMID: 15818618 [PubMed - indexed for MEDLINE]

7:

Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.

Smith DD, Saetrom P, Snøve O Jr, Lundberg C, Rivas GE, Glackin C, Larson GP.

BMC Bioinformatics. 2008 Jan 28;9:63.

PMID: 18226260 [PubMed - indexed for MEDLINE]

8:

Gene expression signature of estrogen receptor alpha status in breast cancer.

Abba MC, Hu Y, Sun H, Drake JA, Gaddis S, Baggerly K, Sahin A, Aldaz CM.

BMC Genomics. 2005 Mar 11;6(1):37.

PMID: 15762987 [PubMed - indexed for MEDLINE]

9:

Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression.

Oudes AJ, Roach JC, Walashek LS, Eichner LJ, True LD, Vessella RL, Liu AY.

BMC Cancer. 2005 Jul 22;5:86.

PMID: 16042785 [PubMed - indexed for MEDLINE]

10:

Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.

Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W.

Cancer Res. 2004 Feb 1;64(3):844-56.

PMID: 14871811 [PubMed - indexed for MEDLINE]

11:

Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts.

Esseghir S, Reis-Filho JS, Kennedy A, James M, O'Hare MJ, Jeffery R, Poulsom R, Isacke CM.

J Pathol. 2006 Dec;210(4):420-30.

PMID: 17054309 [PubMed - indexed for MEDLINE]

12:

Transcription profiles of non-immortalized breast cancer cell lines.

Fernandez-Cobo M, Holland JF, Pogo BG.

BMC Cancer. 2006 Apr 20;6:99.

PMID: 16626496 [PubMed - indexed for MEDLINE]

13:

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL.

J Pathol. 2008 Feb;214(3):357-67.

PMID: 18044827 [PubMed - indexed for MEDLINE]

14:

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.

PMID: 18037662 [PubMed - indexed for MEDLINE]

15:

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM.

Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1176-81.

PMID: 11158614 [PubMed - indexed for MEDLINE]

16:

Gene expression analysis in SV40-immortalized human breast luminal epithelial cells with stem cell characteristics using a cDNA microarray.

Park JS, Noh DY, Kim SH, Kim SH, Kong G, Chang CC, Lee YS, Trosko JE, Kang KS.

Int J Oncol. 2004 Jun;24(6):1545-58.

PMID: 15138599 [PubMed - indexed for MEDLINE]

17:

Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data.

Shen R, Ghosh D, Chinnaiyan AM.

BMC Genomics. 2004 Dec 14;5(1):94.

PMID: 15598354 [PubMed - indexed for MEDLINE]

18:

CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

O'Brien SL, Fagan A, Fox EJ, Millikan RC, Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, Higgins DG, Jirström K, Landberg G, Gallagher WM.

Int J Cancer. 2007 Apr 1;120(7):1434-43.

PMID: 17205517 [PubMed - indexed for MEDLINE]

19:

Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.

Nagahata T, Onda M, Emi M, Nagai H, Tsumagari K, Fujimoto T, Hirano A, Sato T, Nishikawa K, Akiyama F, Sakamoto G, Kasumi F, Miki Y, Tanaka T, Tsunoda T.

Cancer Sci. 2004 Mar;95(3):218-25.

PMID: 15016320 [PubMed - indexed for MEDLINE]

20:

Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype.

Barsky SH.

Exp Mol Pathol. 2003 Apr;74(2):113-22.

PMID: 12710942 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 2062
of 104Next